Collectively, these observations suggest that EPAS1 reduction in obesity may result from hypertriglyceridemia-FFA metabolism coupled to localized alterations in cellular oxidative stress leading to the induction of endothelial PHD2. The gene discussed is EPAS1; the disease is obesity disorder.